BBB Foods Inc. Announces Closing of Secondary Offering

BBB Foods Inc. Announces Closing of Secondary Offering

MEXICO CITY–(BUSINESS WIRE)–
BBB Foods Inc. (“BBB Foods”, “we”, “us”, and “our”) (NYSE: TBBB) announced today the closing of an underwritten public offering of 21,000,000 Class A common shares which were sold by certain selling shareholders at a public offering price of $28.25 per Class A common share. The offering was made pursuant to a registration statement on Form F-1 filed with the U.S. Securities and Exchange Commission (“SEC”).

In connection with the offering, the selling shareholders have granted the underwriters the option to purchase up to 3,150,000 additional Class A common shares at the public offering price, less underwriting discounts and commissions.

J.P. Morgan Securities LLC and Morgan Stanley & Co. LLC are acting as global coordinators and Banco BTG Pactual, S.A. – Cayman Branch, Santander US Capital Markets LLC and Scotia Capital (USA) Inc. are acting as joint bookrunners of this offering.

The offering is being made only by means of a prospectus. When available, copies of the final prospectus related to the offering may be obtained from: J.P. Morgan Securities LLC, c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, NY 11717, or by email at [email protected] and [email protected]; or Morgan Stanley & Co. LLC, Attention: Prospectus Department, 180 Varick Street, 2nd Floor, New York, NY 10014 or by email to: [email protected].

A registration statement on Form F-1 relating to these securities has been filed with, and declared effective by, the SEC. Copies of the registration statement can be accessed through the SEC’s website at www.sec.gov. This press release shall not constitute an offer to sell or a solicitation of an offer to buy the securities described herein, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

About BBB Foods Inc.

BBB Foods Inc., a proudly Mexican company, is a pioneer and leader of the grocery hard discount model in Mexico and one of the fastest growing retailers in the country as measured by its sales and store growth rates. The 3B name, which references “Bueno, Bonito y Barato” – a Mexican saying which translates to “Good, Nice and Affordable” – summarizes Tiendas 3B’s mission of offering irresistible value to budget savvy consumers through great quality products at bargain prices. By delivering value to the Mexican consumer, we believe we contribute to the economic well-being of Mexican families. In a landmark achievement, Tiendas 3B was listed on the New York Stock Exchange in February 2024 under the ticker symbol “TBBB.”

For more information, please visit: https://www.investorstiendas3b.com

Investor Relations Contact

Andrés Villasis

[email protected]

KEYWORDS: Latin America North America United States Mexico Central America

INDUSTRY KEYWORDS: Family Food/Beverage Consumer Retail Supermarket

MEDIA:

Logo
Logo

DNP Select Income Fund Inc. Section 19(a) Notice

DNP Select Income Fund Inc. Section 19(a) Notice

CHICAGO–(BUSINESS WIRE)–
Notification of Sources of Distribution

Distribution Period

January 2025

Distribution Amount Per Share of Common Stock

$0.065

 

The following table sets forth the estimated amounts of the current distribution, payable February 10, 2025 to shareholders of record January 31, 2025, together with the cumulative distributions paid this fiscal year-to-date (YTD) from the following sources. The fiscal year is November 1, 2024 to October 31, 2025. All amounts are expressed per share of common stock based on U.S. generally accepted accounting principles, which may differ from federal income tax regulations.

Distribution Estimates

January 2025

Fiscal YTD

Sources

Per Share Amount

% of Current

Distribution

Per Share Amount

% of Cumulative

Distributions

Net Investment Income

$

0.009

14%

$

0.049

25%

Net Realized Short-Term Capital Gains

 

0.001

2%

 

0.002

1%

Net Realized Long-Term Capital Gains

 

0.055

84%

 

0.144

74%

Return of Capital (or Other Capital Source)

 

 

Total (per common share)

$

0.065

100%

$

0.195

100%

 

November 30, 2024

 

Average annual total return* on NAV for the 5 years

 

 

8.44%

Annualized current distribution rate as a percentage of NAV

 

 

8.21%

Cumulative total return on NAV for the fiscal YTD

 

 

7.13%

Cumulative fiscal YTD distributions as a percentage of NAV

 

 

0.68%

The Fund will issue a separate 19(a) notice at the time of each monthly distribution using the most current financial information available. You should not draw any conclusions about the Fund’s investment performance from the amount of this distribution or from the terms of the Fund’s managed distribution plan.

The amounts and sources of distributions reported in this notice are only estimates and are not being provided for tax reporting purposes. The actual amounts and sources of the amounts for tax reporting purposes will depend upon the Fund’s investment experience during the remainder of the fiscal year and may be subject to changes based on tax regulations. The Fund or your broker will send you a Form 1099-DIV for the calendar year that will tell you how to report these distributions for federal income tax purposes.

* Simple arithmetic average of each of the past five annual returns.

DNP Select Income Fund Inc. (NYSE: DNP) is a closed-end diversified investment management company. The Fund’s primary investment objectives are current income and long-term growth of income. The Fund seeks to achieve these objectives by investing primarily in a diversified portfolio of equity and fixed income securities of companies in the public utilities industry. For more information, visit the Fund’s website at www.dpimc.com/dnp or call the Fund at (800) 864-0629.

Dianna P. Wengler or Donny C. Overton

(833) 604-3163

KEYWORDS: United States North America Illinois

INDUSTRY KEYWORDS: Banking Professional Services Finance

MEDIA:

Logo
Logo

Spyre Therapeutics Announces Grants of Inducement Awards

PR Newswire


WALTHAM, Mass.
, Feb. 7, 2025 /PRNewswire/ — Spyre Therapeutics, Inc. (NASDAQ: SYRE) (the “Company” or “Spyre”), a clinical-stage biotechnology company utilizing best-in-class antibody engineering, rational therapeutic combinations, and precision medicine approaches to target improved efficacy and convenience in the treatment of IBD and other immune-mediated diseases, today announced that Spyre’s independent Compensation Committee of the Board of Directors approved the grant of stock options to purchase 35,000 shares of common stock of Spyre to three non-executive employees as equity inducement awards under the Spyre Therapeutics, Inc. 2018 Equity Inducement Plan, as amended (the “2018 Plan”). The stock options were approved on February 3, 2025 and were material to each employee’s acceptance of employment with Spyre, in accordance with Nasdaq Listing Rule 5635(c)(4).

The stock options were granted with a 10-year term and an exercise price equal to $22.65, the closing price per share of Spyre’s common stock as reported by Nasdaq on February 3, 2025. The options granted to each employee shall vest and become exercisable as to one-fourth (1/4th) of the shares subject to the respective options on the first anniversary of the employee’s start date, and one-forty-eighth (1/48th) of the shares subject to the respective options shall vest and become exercisable monthly thereafter, in each case, subject to continuous service with Spyre through the applicable vesting dates. The stock options are subject to the terms of the 2018 Plan.

About Spyre Therapeutics

Spyre Therapeutics is a clinical-stage biotechnology company that aims to create next-generation inflammatory bowel disease (IBD) and other immune-mediated disease products by combining best-in-class antibody engineering, rational therapeutic combinations, and precision medicine approaches. Spyre’s pipeline includes investigational extended half-life antibodies targeting α4β7, TL1A, and IL-23. For more information, visit Spyre’s website at www.spyre.com.

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/spyre-therapeutics-announces-grants-of-inducement-awards-302371607.html

SOURCE Spyre Therapeutics, Inc.

NexPoint Diversified Real Estate Trust Announces 2024 Dividend Income Tax Treatment

PR Newswire


DALLAS
, Feb. 7, 2025 /PRNewswire/ — NexPoint Diversified Real Estate Trust (“NXDT”) (NYSE: NXDT) announced today the final income allocations of the Company’s 2024 dividend distributions on its common shares and preferred shares. The final income allocations as they will be reported on Form 1099-DIV are set forth in the following table:


Common Shares (CUSIP # 65340G205)


Ex
Dividend
Date


Record
Date


Payable
Date


Distribution
Per Share


Taxable
Ordinary
Income
Per Share


Taxable
Capital
Gain
Distr. Per
Share


Return of
Capital
Per Share


Section
199A
Dividends
Per Share


Qualified
Dividend
Income
Per Share

2/15/2024

2/16/2024

3/28/2024

$0.15000

$0.00000

$0.00000

$0.15000

$0.00000

$0.00000

5/14/2024

5/15/2024

6/28/2024

$0.15000

$0.00000

$0.00000

$0.15000

$0.00000

$0.00000

8/15/2024

8/15/2024

9/30/2024

$0.15000

$0.00000

$0.00000

$0.15000

$0.00000

$0.00000

11/15/2024

11/15/2024

12/31/2024

$0.15000

$0.00000

$0.00000

$0.15000

$0.00000

$0.00000


Totals

$0.60000

$0.00000

$0.00000

$0.60000

$0.00000

$0.00000

100.00 %

0.00 %

0.00 %

100.00 %


Preferred Shares (CUSIP # 65340G304)


Ex
Dividend
Date


Record
Date


Payable
Date


Distribution
Per Share


Taxable
Ordinary
Income
Per Share


Capital Gain
Distributions
Per Share


Return of
Capital
Per Share


Section
199A
Dividends
Per Share


Qualified
Dividend
Income
Per Share

12/21/2023

12/22/2023

1/2/2024

$0.34375

$0.00000

$0.00000

$0.34375

$0.00000

$0.00000

3/22/2024

3/25/2024

4/1/2024

$0.34375

$0.00000

$0.00000

$0.34375

$0.00000

$0.00000

6/24/2024

6/24/2024

7/1/2024

$0.34375

$0.00000

$0.00000

$0.34375

$0.00000

$0.00000

9/23/2024

9/23/2024

9/30/2024

$0.34375

$0.00000

$0.00000

$0.34375

$0.00000

$0.00000

12/23/2024

12/23/2024

12/31/2024

$0.34375

$0.00000

$0.00000

$0.34375

$0.00000

$0.00000


Totals

$1.71875

$0.00000

$0.00000

$1.71875

$0.00000

$0.00000

100.00 %

0.00 %

0.00 %

100.00 %

Components may not sum to the totals due to rounding differences. The information above presents final income allocations.

The Company encourages shareholders to consult with their own tax advisors with respect to the federal, state, and local income tax effects of these dividends.

About NexPoint Diversified Real Estate Trust

NexPoint Diversified Real Estate Trust is an externally advised, publicly traded, diversified real estate investment trust (REIT) focused on the acquisition, development, and management of opportunistic and value-add investments throughout the United States across multiple sectors where NexPoint and its affiliates have operational expertise. NXDT is externally advised by NexPoint Real Estate Advisors X, L.P. For more information, please visit nxdt.nexpoint.com.

CONTACTS

Investor Relations

Kristen Griffith

[email protected]

Media Relations

[email protected]

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/nexpoint-diversified-real-estate-trust-announces-2024-dividend-income-tax-treatment-302371598.html

SOURCE NexPoint Diversified Real Estate Trust

NexPoint Real Estate Finance Announces 2024 Dividend Income Tax Treatment

PR Newswire


DALLAS
, Feb. 7, 2025 /PRNewswire/ — NexPoint Real Estate Finance, Inc. (NYSE: NREF) (the “Company”) announced today the final income allocations of the Company’s 2024 dividend distributions on its common stock, Series A Preferred Stock and Series B Preferred Stock. The final income allocations as they will be reported on Form 1099-DIV are set forth in the following table:


Common Shares (CUSIP #65342V101)


Ex
Dividend
Date


Record
Date


Payable
Date


Distribution
Per Share


Taxable
Ordinary
Income
Per Share (1)


Return of
Capital
Per Share

3/14/2024

3/15/2024

3/28/2024

$0.50000

$0.45344

$0.04656

6/14/2024

6/14/2024

6/28/2024

$0.50000

$0.45344

$0.04656

9/13/2024

9/13/2024

9/30/2024

$0.50000

$0.45344

$0.04656

12/13/2024

12/13/2024

12/31/2024

$0.50000

$0.45344

$0.04656


Totals

$2.00000

$1.81376

$0.18624

100.00 %

90.69 %

9.31 %

 


Series A Preferred Shares (CUSIP #65342V408)


Ex
Dividend
Date


Record
Date


Payable
Date


Distribution
Per Share


Taxable
Ordinary
Income
Per Share (1)


Return of
Capital
Per Share

1/11/2024

1/12/2024

1/25/2024

$0.53125

$0.53125

$0.00000

4/12/2024

4/15/2024

4/25/2024

$0.53125

$0.53125

$0.00000

7/15/2024

7/15/2024

7/25/2024

$0.53125

$0.53125

$0.00000

10/15/2024

10/15/2024

10/25/2024

$0.53125

$0.53125

$0.00000


Totals

$2.12500

$2.12500

$0.00000

100.00 %

100.00 %

0.00 %

 


Series B Preferred Shares (Various CUSIPs)


Ex
Dividend
Date


Record
Date


Payable
Date


Distribution
Per Share


Taxable
Ordinary
Income
Per Share (1)


Return of
Capital
Per Share

1/24/2024

1/25/2024

2/5/2024

$0.18750

$0.18750

$0.00000

2/22/2024

2/23/2024

3/5/2024

$0.18750

$0.18750

$0.00000

3/22/2024

3/25/2024

4/5/2024

$0.18750

$0.18750

$0.00000

4/24/2024

4/25/2024

5/6/2024

$0.18750

$0.18750

$0.00000

5/23/2024

5/24/2024

6/5/2024

$0.18750

$0.18750

$0.00000

6/25/2024

6/25/2024

7/5/2024

$0.18750

$0.18750

$0.00000

7/25/2024

7/25/2024

8/5/2024

$0.18750

$0.18750

$0.00000

8/23/2024

8/23/2024

9/5/2024

$0.18750

$0.18750

$0.00000

9/25/2024

9/25/2024

10/7/2024

$0.18750

$0.18750

$0.00000

10/25/2024

10/25/2024

11/5/2024

$0.18750

$0.18750

$0.00000

11/25/2024

11/25/2024

12/5/2024

$0.18750

$0.18750

$0.00000

12/24/2024

12/24/2024

1/6/2025

$0.18750

$0.18750

$0.00000


Totals

$2.25

$2.25

$0.00000

100.00 %

100.00 %

0.00 %

(1) 99.24% of the amount reported as Taxable Ordinary Income is treated as a qualified REIT dividend for purposes of Section 199A. 0.76% of the amount reported as Taxable Ordinary Income is designated as qualified dividend income pursuant to Section 857(c)(2).

 

About NexPoint Real Estate Finance, Inc.

NexPoint Real Estate Finance, Inc., is a publicly traded REIT, with its common stock and Series A Preferred Stock listed on the New York Stock Exchange under the symbols “NREF” and “NREF-PRA,” respectively, primarily focused on originating, structuring and investing in first-lien mortgage loans, mezzanine loans, preferred equity, convertible notes, multifamily properties and common equity investments, as well as multifamily and single-family rental commercial mortgage-backed securities securitizations, promissory notes and mortgage-backed securities.  More information about the Company is available at nref.nexpoint.com.

CONTACTS

Investor Relations

Kristen Griffith

[email protected]

Media Relations

[email protected]

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/nexpoint-real-estate-finance-announces-2024-dividend-income-tax-treatment-302371606.html

SOURCE NexPoint Real Estate Finance, Inc.

Bit Digital, Inc. Announces Monthly Production Update for January 2025

PR Newswire


NEW YORK
, Feb. 7, 2025 /PRNewswire/ — Bit Digital, Inc. (Nasdaq: BTBT) (“Bit Digital” or the “Company”), a global platform for high-performance computing (“HPC”) infrastructure and digital asset production headquartered in New York, announced its unaudited digital asset production, HPC services revenue, and corporate updates for the month of January 2025.

 Corporate Highlights for January 2025

  • The Company earned approximately $4.9 million of total unaudited HPC revenue[1] during the month of January 2025.
  • Treasury holdings of BTC and ETH were 768.7 and 27,689.6 with a fair market value of approximately $78.7 million and $91.3 million, respectively, on January 31, 2025.
  • The BTC equivalent[2] of our digital asset holdings as of January 31, 2025, was approximately 1,663.0 or approximately $170.3 million.
  • The Company had cash and cash equivalents of $74.3 million and total liquidity (defined as cash and cash equivalents, USDC, and the fair market value of digital assets) of approximately $244.6 million in January 2025.

Colocation Services Revenue Highlights

  • The Company had 14 customers actively generating revenue at its Tier-3 Enovum Data Center facility, as of January 31, 2025.
  • The Company’s HPC data center colocation revenue was approximately CAD $757.8k (approximately USD $522.9k) in January 2025.

GPU Cloud Highlights

  • The Company had 268 servers (2,144 GPUs) actively generating revenue from its Bit Digital AI contracts, as of January 31, 2025. The Company earned approximately $4.4 million of total unaudited GPU Cloud revenue during the month of January 2025. In addition, the Company received $131K in cash payments from its equipment leasing contract with Boosteroid during the month of January 2025.
  • On January 22, Bit Digital entered into a new agreement with a key customer for 464 Nvidia B200 GPUs, expanding its GPU Cloud business. This new agreement replaces a prior agreement whereby the Company was to provide the customer with an incremental 2,048 H100 GPUs and the Company continues to explore additional GPU contracts with this customer for 2025. Under the terms of the agreement, Bit Digital will provide the customer with 58 Nvidia B200 servers (464 GPUs) for a period of eighteen months. The contract represents approximately $15 million of annualized revenue for Bit Digital and features a two-month prepayment from the customer.

Digital Assets Highlights

  • In January 2025, the Company produced 28.7 BTC, an 11.4% decrease compared to the prior month. The decrease was primarily driven by a change in the Company’s hosting portfolio, ongoing redeployment of mining assets to new sites, and the retirement of older generation miners.
  • In January 2025, the Company’s active hash rate was approximately 1.6 EH/s, an 11.1% decrease compared to the prior month. The decrease was primarily driven by a change in the Company’s hosting portfolio, ongoing redeployment of mining assets to new sites, and the retirement of older generation miners.
  • 191 Bitmain Antminer S21 mining units were delivered to a new hosting site in the month of January 2025.
  • The Company had approximately 21,568 ETH actively staked in native staking protocols as of January 31, 2025.
  • Bit Digital earned a blended APY of approximately 3.6% on its staked ETH position for the month of January 2025.
  • The Company earned aggregate staking rewards of approximately 65.8 ETH during January 2025.

Other Highlights

  • As of January 1, 2025, the Company officially transitioned to domestic issuer status under U.S. securities regulations.

Upcoming Events

  • Fireside Chat with H.C. Wainwright on February 12.

About Bit Digital

Bit Digital, Inc. is a global platform for high-performance computing (“HPC”) infrastructure and digital asset production headquartered in New York City. The Company’s HPC business operates under the WhiteFiber Inc. (“WhiteFiber”) brand. Our operations are located in the US, Canada, and Iceland. For additional information, please contact [email protected] or visit our website at www.bit-digital.com.

Investor Notice

Investing in our securities involves a high degree of risk. Before making an investment decision, you should carefully consider the risks, uncertainties and forward-looking statements described under “Risk Factors” in Item 3.D of our Annual Report on Form 20-F for the fiscal year ended December 31, 2023 (“Annual Report”). Notwithstanding the fact that Bit Digital Inc. has not conducted operations in the PRC since September 30, 2021 we have previously disclosed under Risk Factors in our Annual Report: “We may be subject to fines and penalties for any noncompliance with or any liabilities in our former business in China in a certain period from now on.” Although the statute of limitations for non-compliance by our former business in the PRC is generally two years and the Company has been out of the PRC, for more than two years, the Authority may still find its prior bitcoin mining operations involved a threat to financial security. In such event, the two-year period would be extended to five years. If any material risk was to occur, our business, financial condition or results of operations would likely suffer. In that event, the value of our securities could decline and you could lose part or all of your investment. The risks and uncertainties we describe are not the only ones facing us. Additional risks not presently known to us or that we currently deem immaterial may also impair our business operations. In addition, our past financial performance may not be a reliable indicator of future performance, and historical trends should not be used to anticipate results in the future. Future changes in the network-wide mining difficulty rate or bitcoin hash rate may also materially affect the future performance of Bit Digital’s production of bitcoin. Actual operating results will vary depending on many factors including network difficulty rate, total hash rate of the network, the operations of our facilities, the status of our miners, and other factors. See “Safe Harbor Statement” below.

Safe Harbor Statement

This press release may contain certain “forward-looking statements” relating to the business of Bit Digital, Inc., and its subsidiary companies. All statements, other than statements of historical fact included herein are “forward-looking statements.” These forward-looking statements are often identified by the use of forward-looking terminology such as “believes,” “expects,” or similar expressions, involving known and unknown risks and uncertainties. Although the Company believes that the expectations reflected in these forward-looking statements are reasonable, they do involve assumptions, risks and uncertainties, and these expectations may prove to be incorrect. Investors should not place undue reliance on these forward-looking statements, which speak only as of the date of this press release. The Company’s actual results could differ materially from those anticipated in these forward-looking statements as a result of a variety of factors, including those discussed in the Company’s periodic reports that are filed with the Securities and Exchange Commission and available on its website at http://www.sec.gov. All forward-looking statements attributable to the Company or persons acting on its behalf are expressly qualified in their entirety by these factors. Other than as required under the securities laws, the Company does not assume a duty to update these forward-looking statements.

[1] Total HPC Revenue includes GPU Cloud revenue and Colocation services revenue. This figure excludes revenue from signed contracts that have not yet commenced. Cash payments from its equipment leasing contract with Boosteroid are also not included in Total HPC Revenue for accounting reasons.

[2] “BTC equivalent” is a hypothetical illustration of the value of our digital asset treasury holdings in bitcoin terms. BTC equivalent is defined as if all non-BTC digital assets, comprised of ETH, and USDC, were converted into BTC as of January 31, 2025, and added to our existing BTC balance. Conversion values are found using the closing price on coinmarketcap.com. Our digital asset portfolio excludes digital assets invested in a third-party managed fund.

 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/bit-digital-inc-announces-monthly-production-update-for-january-2025-302371483.html

SOURCE Bit Digital, Inc.

Pliant Therapeutics Provides Update on BEACON-IPF, a Phase 2b/3 Trial in Patients with Idiopathic Pulmonary Fibrosis

Following DSMB recommendation, the Company has voluntarily paused enrollment and dosing in the BEACON-IPF Phase 2b trial and will monitor current patients while data is reviewed

SOUTH SAN FRANCISCO, Calif., Feb. 07, 2025 (GLOBE NEWSWIRE) — Pliant Therapeutics, Inc. (Nasdaq: PLRX) today announced that following a prespecified data review and recommendations by the trial’s independent Data Safety Monitoring Board (DSMB), the Company has voluntarily paused enrollment and dosing in the ongoing BEACON-IPF Phase 2b trial of bexotegrast in patients with idiopathic pulmonary fibrosis (IPF). Patients currently enrolled in BEACON-IPF will remain in the trial.

Enrollment and dosing have been paused while data is reviewed to understand the DSMB’s rationale for their recommendation. Blinding of the study will be maintained to preserve trial integrity. The Company has informed BEACON-IPF clinical trial investigators and is in the process of informing global regulatory authorities.

About Pliant Therapeutics, Inc.

Pliant Therapeutics is a late-stage biopharmaceutical company and leader in the discovery and development of novel therapeutics for the treatment of fibrotic diseases. Pliant’s lead product candidate, bexotegrast (PLN-74809), is an oral, small molecule, dual selective inhibitor of αvß6 and αvß1 integrins that is in development in the lead indication for the treatment of idiopathic pulmonary fibrosis, or IPF. Bexotegrast has received Fast Track Designation and Orphan Drug Designation from the U.S. Food and Drug Administration (FDA) and Orphan Drug Designation from the European Medicines Agency in IPF. Pliant has initiated BEACON-IPF, an adaptive Phase 2b/3 trial of bexotegrast in IPF. Pliant is conducting a Phase 1 study for its third clinical program, PLN-101095, a small molecule, dual-selective inhibitor of αvß8 and αvß1 integrins, that is being developed for the treatment of solid tumors. In addition, Pliant has received regulatory clearance for the conduct of a Phase 1 study of PLN-101325, a monoclonal antibody agonist of integrin α7β1 targeting muscular dystrophies.

For additional information, please visit: www.PliantRx.com. Follow us on social media XLinkedIn, and Facebook.

Forward-Looking Statements

Statements contained in this press release regarding matters that are not historical facts are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Words such as “may,” “will,” “expect,” “anticipate,” “estimate,” “intend,” and similar expressions (as well as other words or expressions referencing future events, conditions, or circumstances) are intended to identify forward-looking statements. These statements include those regarding the Company’s and the DSMB’s further review and analysis of data, interactions with the DSMB and global regulatory authorities, and the Company’s current and future plans for bexotegrast and the BEACON-IPF clinical trial. Because such statements deal with future events and are based on our current expectations, they are subject to various risks and uncertainties and actual results, performance or achievements of Pliant Therapeutics could differ materially from those described in or implied by the statements in this press release. These forward-looking statements are subject to risks and uncertainties, including those related to the development and commercialization of our product candidates, including any delays in our ongoing or planned preclinical or clinical trials, the risks inherent in the drug development process, the risks regarding the accuracy of our estimates of expenses and timing of development, and our capital requirements and the need for additional financing, including the availability of additional term loans under our loan facility. These and additional risks are discussed in the sections titled “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in our Quarterly Report on Form 10-Q for the period ended September 30, 2024, which is available on the SEC’s website at www.sec.gov. Unless otherwise noted, Pliant is providing this information as of the date of this news release and does not undertake any obligation to update any forward-looking statements contained in this document as a result of new information, future events or otherwise.

Investor and Media Contact:

Christopher Keenan
Vice President, Investor Relations and Corporate Communications
Pliant Therapeutics, Inc.
[email protected]



Tidal Financial Group and CNIC Funds Announces the Closure of the CNIC ICE U.S. Carbon Neutral Power Futures Index ETF (NYSE: AMPD)

MILWAUKEE, Feb. 07, 2025 (GLOBE NEWSWIRE) — Tidal Financial Group and CNIC Funds today announced the planned closure and liquidation of the CNIC ICE U.S. Carbon Neutral Power Futures Index ETF (NYSE: AMPD). The Board of Trustees of Tidal Trust II concluded that liquidating and closing the Fund would be in the best interest of the Fund and its shareholders.

The ETF will cease trading on the New York Stock Exchange (NYSE) at the close of regular trading on February 18, 2025 [Closing Date], and it will no longer accept purchase orders as of that date.

Shareholders may sell their holdings in the fund prior to the Closing Date through standard brokerage transactions, which may be subject to customary brokerage fees. After the Closing Date, shareholders will be unable to buy or sell shares on an exchange and may only redeem shares through select broker-dealers, with no assurance of an active market during this period.

Between February 18, 2025 and February 20, 2025 [Liquidation Date], AMPD will begin liquidating its holdings, increasing its cash position in preparation for final distribution. As a result, the fund’s investment holdings will deviate from its stated investment objectives.

On or around the Liquidation Date, AMPD will distribute its remaining net assets to shareholders of record who have not otherwise sold their shares prior to liquidation. This distribution will be made in cash on a pro rata basis and will generally be treated as a taxable event. Shareholders are encouraged to consult their tax advisers regarding potential implications related to capital gains, losses, or dividends associated with the liquidation.

Following these distributions, the fund will officially terminate.

About Tidal Financial Group

Formed by ETF industry pioneers and thought leaders, Tidal Investments LLC sets out to revolutionize the way ETFs have historically been developed, launched, marketed, and sold. With a focus on growing AUM, Tidal offers a comprehensive suite of services, proprietary tools, and methodologies designed to bring lasting ideas to market. Tidal is an advocate for ETF innovation. The firm is on a mission to provide issuers with the intelligence and tools needed to efficiently and to effectively launch ETFs and to optimize growth potential in a highly competitive space. For more information, visit https://www.tidalfinancialgroup.com/.

Contact Gavin Filmore at [email protected] for more information.



Mexco Energy Corporation Reports Financial Results for Third Quarter

MIDLAND, TX, Feb. 07, 2025 (GLOBE NEWSWIRE) — Mexco Energy Corporation (NYSE American: MXC) today reported net income of $1,077,370, or $0.51 per diluted share, for the nine months ending December 31, 2024.

Operating revenues in the first nine months of fiscal 2025 were $5,368,327, an increase of 12% when compared to the first nine months of fiscal 2024. This increase was primarily due to an increase in oil and natural gas production volumes and partially offset by a decrease in the average sales prices of oil and natural gas. Natural gas prices have been low due to limited pipeline capacities in the Permian Basin. Oil contributed to 86% of our operating revenues for the first nine months of fiscal 2025.

Net income of $469,133, or $0.22 per diluted share, for the Company’s third quarter of fiscal 2025, an increase of 36% compared to $345,610, or $0.16 per diluted share, for the third quarter of fiscal 2024. Operating revenues in the third quarter of fiscal 2025 were $1,891,265.

The Company currently expects to participate in the drilling of 28 and completion of 19 horizontal wells at an estimated aggregate cost of approximately $1.8 million for the fiscal year ending March 31, 2025, of which $1.1 million has been expended to date.

Also, the Company has expended to date, approximately $2 million for royalty and mineral interest acquisitions in approximately 700 producing wells with additional potential development located in 37 counties in 9 states.

Mexco Energy Corporation, a Colorado corporation, is an independent oil and gas company located in Midland, Texas engaged in the acquisition, exploration and development of oil and gas properties primarily in the Permian Basin. For more information on Mexco Energy Corporation, go to www.mexcoenergy.com.

In accordance with the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995, Mexco Energy Corporation cautions that statements in this press release which are forward-looking and which provide other than historical information involve risks and uncertainties that may impact the Company’s actual results of operations. These risks include, but are not limited to, production variance from expectations, volatility of oil and gas prices, the need to develop and replace reserves, exploration risks, uncertainties about estimates of reserves, competition, government regulation, and mechanical and other inherent risks associated with oil and gas production. A discussion of these and other factors, including risks and uncertainties, is set forth in the Company’s Form 10-K for the fiscal year ended March 31, 2024. Mexco Energy Corporation disclaims any intention or obligation to revise any forward-looking statements.

For additional information, please contact: Tammy L. McComic, President and Chief Financial Officer, at Mexco Energy Corporation, (432) 682-1119.


DWS Municipal Income Trust Declares Monthly Distribution

DWS Municipal Income Trust Declares Monthly Distribution

NEW YORK–(BUSINESS WIRE)–DWS Municipal Income Trust (KTF) (the “Fund”) announced today its regular February monthly distribution.

Details are as follows:

Declaration – 2/07/2025

Ex-Date – 02/20/2025

Record – 02/20/2025

Payable – 02/28/2025

Fund

Ticker

 

Distribution

Per Share

Prior

Distribution

Per Share

DWS Municipal Income Trust

KTF

$0.0610

$0.0610

The Fund intends to distribute all or substantially all of its net investment income each year through its regular monthly distributions and to distribute any realized capital gains at least annually. In addition, in any monthly period, to maintain its declared per common share distribution amount, the Fund may distribute more or less than its net investment income during the period. In the event the Fund distributes more than its net investment income during any yearly period, such distributions may also include realized gains and/or a return of capital. When distributions exceed total return performance, the difference will reduce the Fund’s net asset value.

It is estimated that a portion of the Fund’s February distribution consists of a return of capital. A return of capital may occur, for example, when some or all of a shareholder’s investment is paid back to the shareholder. A return of capital distribution does not necessarily reflect a fund’s investment performance and should not be confused with “yield” or “income.” Shareholders should not draw any conclusions about the Fund’s investment performance from the amount of its monthly distribution. As required by Federal securities laws, the Fund will issue a notice to its common shareholders in connection with its monthly distribution that contains information about the amount and estimated sources of the distribution and other related information. The final determination of the source and tax status of all distributions paid in 2025 will be made after the end of 2025 and will be provided on Form 1099-DIV.

Important Information

DWS Municipal Income Trust. Bond investments are subject to interest-rate, credit, liquidity and market risks to varying degrees. When interest rates rise, bond prices generally fall. Credit risk refers to the ability of an issuer to make timely payments of principal and interest. Municipal securities are subject to the risk that litigation, legislation or other political events, local business or economic conditions or the bankruptcy of the issuer could have a significant effect on an issuer’s ability to make payments of principal and/or interest. The market for municipal bonds may be less liquid than for taxable bonds, and there may be less information available on the financial condition of issuers of municipal securities than for public corporations. Investing in derivatives entails special risks relating to liquidity, leverage and credit that may reduce returns and/or increase volatility. Leverage results in additional risks and can magnify the effect of any gains or losses. Although the Fund seeks income that is exempt from federal income taxes, a portion of the Fund’s distributions may be subject to federal, state and local taxes, including the alternative minimum tax.

Closed-end funds, unlike open-end funds, are not continuously offered. There is a one-time public offering and once issued, shares of closed-end funds are bought and sold in the open market through a stock exchange. Shares of closed-end funds frequently trade at a discount to the net asset value. The price of a fund’s shares is determined by a number of factors, several of which are beyond the control of the fund. Therefore, the fund cannot predict whether its shares will trade at, below or above net asset value.

Past performance is no guarantee of future results.

This press release shall not constitute an offer to sell or a solicitation to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer or solicitation or sale would be unlawful prior to registration or qualification under the laws of such state or jurisdiction.

Certain statements contained in this release may be forward-looking in nature. These include all statements relating to plans, expectations, and other statements that are not historical facts and typically use words like “expect,” “anticipate,” “believe,” “intend,” ”estimated” and similar expressions. Such statements represent management’s current beliefs, based upon information available at the time the statements are made, with regard to the matters addressed. All forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially from those expressed in, or implied by, such statements. Management does not undertake any obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise. The following factors, among others, could cause actual results to differ materially from forward-looking statements: (i) the effects of adverse changes in market and economic conditions; (ii) legal and regulatory developments; and (iii) other additional risks and uncertainties, including public health crises (including the pandemic spread of viruses), war, terrorism, trade disputes and related geopolitical events.

War, terrorism, sanctions, economic uncertainty, trade disputes, public health crises and related geopolitical events have led, and, in the future, may lead to significant disruptions in US and world economies and markets, which may lead to increased market volatility and may have significant adverse effects on the Fund and its investments.

NOT FDIC/ NCUA INSURED • MAY LOSE VALUE • NO BANK GUARANTEE

NOT A DEPOSIT • NOT INSURED BY ANY FEDERAL GOVERNMENT AGENCY

DWS Distributors, Inc.

222 South Riverside Plaza

Chicago, IL 60606-5808

www.dws.com

Tel (800) 621-1148

© 2025 DWS Group GmbH & Co. KGaA. All rights reserved.

The brand DWS represents DWS Group GmbH & Co. KGaA and any of its subsidiaries such as DWS Distributors, Inc. which offers investment products or DWS Investment Management Americas, Inc. and RREEF America L.L.C. which offer advisory services. (R-104572- 1) (02/25)

For additional information:

DWS Press Office (212) 454-4500

Shareholder Account Information (800) 294-4366

DWS Closed-End Funds (800) 349-4281

KEYWORDS: United States North America New York

INDUSTRY KEYWORDS: Other Professional Services Asset Management Professional Services Finance

MEDIA:

Logo
Logo